01 January 2015

Variation of serum erythropoietin ( EPO, a), soluble transferrin receptors ( sTfR, b) and ferritin ( Ferritin, c)

AI00161.jpg
Richalet J-P,Rivera M,Maignan M,Pham I,Privat C,Leon-Velarde F.Pulmonary hypertension and monges disease. [Internet]. 2009 ;1:114. Available from:http://www.pvrireview.org/text.asp?2009/1/2/114/50730

Variation of serum erythropoietin ( EPO, a), soluble transferrin receptors ( sTfR, b) and ferritin ( Ferritin, c), after treatment by 250 mg (D250) or 500 mg (D500) of ACZ compared to CMS placebo-treated group (Placebo) and normal control subjects (Control). Data are mean SD. *, **, ***, P < 0.05, P < 0.01 and P < 0.001 after versus before treatment. #, ###, P < 0.05 and P < 0.001 versus Placebo.

 

Additional keywords: EPO,chronic mountain sickness,ferritin

Science that starts with a hello.

Through global collaboration, we make today's work, tomorrow's possibility.

Join the PVRI
standard-example-image.jpg